Study on 10 heavy proteinuria cases of HSPN with good susceptibility toward combination therapy

We examined 10 pediatric heavy proteinuria cases of Henoch-Schönlein purpura nephritis (HSPN). They all showed good clinical course by using combination therapy including steroid, ACEI and ARB. Eight patients continuously showed heavy proteinuria (urinary protein excretion of >1.0 g/day/m2 body s...

Full description

Saved in:
Bibliographic Details
Published inJapanese journal of pediatric nephrology Vol. 25; no. 2; pp. 110 - 113
Main Authors Eguchi, Hironobu, Yamamura, Tomohiko, Matsumoto, Shinsuke, Hiramoto, Ryugo, Akikusa, Bunshiro
Format Journal Article
LanguageJapanese
Published The Japanese Society for Pediatric Nephrology 30.11.2012
Subjects
angiotensin converting enzyme inhibitor, angiotensin II receptor blocker
child
Henoch-Schönlein purpura nephritis
steroid
Online AccessGet full text

Cover

More Information
Summary:We examined 10 pediatric heavy proteinuria cases of Henoch-Schönlein purpura nephritis (HSPN). They all showed good clinical course by using combination therapy including steroid, ACEI and ARB. Eight patients continuously showed heavy proteinuria (urinary protein excretion of >1.0 g/day/m2 body surface area or urine protein-creatinine ratio in the first morning urine of >1.0 g/g) for longer than 1-2 months, and 2 patient showed hypoalbuminemia of < 3.0 g/dL at the onset. Their proteinuria disappeared relatively smoothly after the introduction of treatment. The pathological findings on second renal biopsy revealed improvement in all cases. The close observation for longer than 18 months has been carried out after the cessation of steroid administration. No proteinuria has appeared since then. This study indicates a possibility of effectiveness of combination therapy including steroid, ACEI and ARB for HSPN patients with severe proteinuria.
ISSN:0915-2245
1881-3933
DOI:10.3165/jjpn.25.110